Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
≤10
General Information
Version
Regulatory Affairs
Revision date
2021-01-25
Product name
Bivalirudin for Injection
supplier name
Meitheal Pharmaceuticals, Inc
Emergency telephone
844-824-8426 (Monday - Friday, 08 00 - 18 00 CST
Icons in SDS
Company Information
company name
Meitheal Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info@meithealpharma.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
COMBUSTIBLE DUSTS H315 SKIN IRRITATION - Category 2 H319 EYE IRRITATION - Category 2A
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. SDS Title: SDS Number: Page Number: Bivalirudin for Injection Safety Data Sheet SDS-000042 Page 2 of 14 Function: Date of issue/ Date of Version number: Regulatory Affairs January 25, 2021 1.0
Prevention
P280 - Wear protective gloves. Wear eye or face protection. P264 - Wash thoroughly after handling.
Response
P362 + P364 - Take off contaminated clothing and wash it before reuse. P302 + P352 - IF ON SKIN: Wash with plenty of water. P332 + P313 - If skin irritation occurs: Get medical advice or attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Keep container tightly closed. Keep away from heat, hot surfaces, sparks, open flames elements and other ignition sources. No smoking. Prevent dust accumulation.
2.3 Other hazards
None known.
